NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer Aug 1, 2024 07:00AM
Aptose to Participate in RBC Capital Markets 2023 Global Healthcare Conference May 4, 2023 07:01AM
Aptose to Present at 2022 RBC Capital Markets Global Healthcare Conference May 3, 2022 07:30AM
Aptose to Present at Upcoming Investor Conferences May 12, 2021 07:30AM
Aptose Biosciences (APTO) Prices 10.5M Share Common Offering at $5.25/Sh Jul 16, 2020 06:04AM


Jul 15, 2020 10:49PM Aptose Announces Pricing of Public Offering of Common Shares
May 7, 2020 07:30AM Aptose to Present at 2020 RBC Capital Markets Global Healthcare Virtual Conference
Jun 3, 2019 08:38AM Aptose Announces Closing of Public Offering of Common Shares
May 30, 2019 09:05AM Aptose Biosciences (APTO) Prices 10M Share Common Offering at $1.85/Sh
May 30, 2019 09:01AM Aptose Announces Pricing of Public Offering of Common Shares
May 29, 2019 04:23PM Aptose Biosciences (APTO) Commences Public Offering of Common Shares
May 29, 2019 04:22PM Aptose Announces Proposed Public Offering of Common Shares
May 13, 2019 08:15AM Aptose to Present at May Investor Conferences
Mar 1, 2019 06:30AM RBC Capital Starts Aptose Biosciences (APTO) at Outperform; Positive on CG-806
Feb 18, 2016 05:00PM Aptose to Present at the 2016 RBC Capital Markets Global Healthcare Conference
Nov 20, 2015 11:37AM Aptose Biosciences' (APTO) APTO-253 Clinical Hold Not Seen as Safety Issue - RBC